Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
HIV vaccine development
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Approaches to destroying or damaging the virion or its parts (Stage I-VII)=== Here, "damage" means inhibiting or stopping the ability of virion to process any of the ''Phase II-VII''. Here are the different classification of methods: * By nature of method: ** Physical methods (''Stage I-VII'') ** Chemical and biological methods (''Stage I-VII'') * By damaging target of the [[HIV#Structure and genome|HIV virion structure]]:<ref>{{cite journal | vauthors = McGovern SL, Caselli E, Grigorieff N, Shoichet BK | title = A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening | journal = Journal of Medicinal Chemistry | volume = 45 | issue = 8 | pages = 1712β22 | date = April 2002 | pmid = 11931626 | doi = 10.1021/jm010533y }}</ref><ref>Compared with overview in: Fisher, Bruce; Harvey, Richard P.; Champe, Pamela C. (2007). Lippincott's Illustrated Reviews: Microbiology (Lippincott's Illustrated Reviews Series). Hagerstown, MD: Lippincott Williams & Wilkins. {{ISBN|0-7817-8215-5}}. Page 3</ref> ** Damaging the [[Envelope glycoprotein GP120|Docking Glycoprotein gp120]]<ref>{{cite report | title = HIV Sequence Compendium | year = 2017 | vauthors = Foley B, Leitner T, Apetrei C, Hahn B, Mizrachi I, Mullins J, Rambaut A, Wolinsky S, Korber B | publisher = Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, NM, LA-UR 17-25240 }}</ref> (''Stage I-III, VI, VII'') ** Damaging the [[Gp41|Transmembrane Glycoprotein gp41]]<ref>{{cite journal | vauthors = Malashkevich VN, Chan DC, Chutkowski CT, Kim PS | title = Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 95 | issue = 16 | pages = 9134β9 | date = August 1998 | pmid = 9689046 | pmc = 21304 | doi = 10.1073/pnas.95.16.9134 | bibcode = 1998PNAS...95.9134M | doi-access = free }}</ref> (''Stage I-III, VI, VII'') ** Damaging the virion matrix (''Stage I-III, VI, VII'') ** Damaging the virion Capsid (''Stage I-III, VI, VII'') ** Damaging the Reverse Transcriptase (''Stage I-VII'') ** Damaging the RNA (''Stage I-VII'')
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
HIV vaccine development
(section)
Add topic